ライブラリ登録: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

年間 6 号発行

ISSN 印刷: 0743-4863

ISSN オンライン: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Pulmonary Drug Delivery: Physiologic and Mechanistic Aspects

巻 14, 発行 4, 1997, 59 pages
DOI: 10.1615/CritRevTherDrugCarrierSyst.v14.i4.20
Get accessGet access

要約

Peptide and protein drugs are being used increasingly in major research and development programs in the pharmaceutical industry and are also an important class of therapeutic agents due to advances in genetic engineering and biotechnology. Systemic delivery of these macromolecular drugs, however, has been limited to the parenteral route largely because of their extensive presystemic elimination when taken orally. Faced with this dilemma concerning the systemic delivery of these macromolecules with their unique conformational complexity for therapeutic activity, pharmaceutical scientists have evaluated the potential of various non-oral routes of administration as alternatives. Despite the tremendous efforts that have been devoted to this problem, only limited success has been achieved—mostly with small peptides. Growing attention has been given to the potential of a pulmonary route as an alternative non-invasive means for systemic delivery of peptide/protein-based therapeutic agents due to the fact that the lung provides a huge but extremely thin absorptive mucosal membrane. Although current studies show great promise, pulmonary delivery of therapeutic peptides and proteins is complicated by the complexity of the anatomic structure of the human respiratory system and the influence on drug deposition exerted by respiration. This review discusses the fundamental structure and physiology of the human respiratory system, current methodology used to study pulmonary drug absorption, approaches of drug delivery to the distal lung, and recent progress in pulmonary drug delivery by case studies. The mechanisms of pulmonary drug absorption are also discussed.

によって引用された
  1. Fujioka Hideki, Grotberg James B., Steady Propagation of a Liquid Plug in a Two-Dimensional Channel, Journal of Biomechanical Engineering, 126, 5, 2004. Crossref

  2. Cassidy K. J. , Gavriely N. , Grotberg J. B. , Liquid Plug Flow in Straight and Bifurcating Tubes , Journal of Biomechanical Engineering, 123, 6, 2001. Crossref

  3. Olgac Ufuk, Muradoglu Metin, Computational modeling of unsteady surfactant-laden liquid plug propagation in neonatal airways, Physics of Fluids, 25, 7, 2013. Crossref

  4. Depreter Flore, Pilcer Gabrielle, Amighi Karim, Inhaled proteins: Challenges and perspectives, International Journal of Pharmaceutics, 447, 1-2, 2013. Crossref

  5. Nahar Kamrun, Gupta Nilesh, Gauvin Robert, Absar Shahriar, Patel Brijeshkumar, Gupta Vivek, Khademhosseini Ali, Ahsan Fakhrul, In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals, European Journal of Pharmaceutical Sciences, 49, 5, 2013. Crossref

  6. Aerosols, Bubbles, and Foams, in Surfactants and Polymers in Drug Delivery, 122, 2002. Crossref

  7. Fujioka Hideki, Grotberg James B., The steady propagation of a surfactant-laden liquid plug in a two-dimensional channel, Physics of Fluids, 17, 8, 2005. Crossref

  8. Beck-Broichsitter Moritz, Schweiger Christoph, Schmehl Thomas, Gessler Tobias, Seeger Werner, Kissel Thomas, Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery, Journal of Controlled Release, 158, 2, 2012. Crossref

  9. Beck-Broichsitter Moritz, Prüfer Nadine, Oesterheld Nina, Seeger Werner, Schmehl Thomas, Nebulization of Active Pharmaceutical Ingredients with the eFlow®rapid: Impact of Formulation Variables on Aerodynamic Characteristics, Journal of Pharmaceutical Sciences, 103, 8, 2014. Crossref

  10. Mehanna Mohammed M., Mohyeldin Salma M., Elgindy Nazik A., Respirable nanocarriers as a promising strategy for antitubercular drug delivery, Journal of Controlled Release, 187, 2014. Crossref

  11. Jalalipour Monireh, Najafabadi Abdolhossien Rouholamini, Gilani Kambiz, Esmaily Hadi, Tajerzadeh Hosnieh, Effect of dimethyl‐β‐cyclodextrin concentrations on the pulmonary delivery of recombinant human growth hormone dry powder in rats, Journal of Pharmaceutical Sciences, 97, 12, 2008. Crossref

  12. Li Hao-Ying, Seville Peter C., Novel pMDI formulations for pulmonary delivery of proteins, International Journal of Pharmaceutics, 385, 1-2, 2010. Crossref

  13. Di Gioia Sante, Trapani Adriana, Castellani Stefano, Carbone Annalucia, Belgiovine Giuliana, Craparo Emanuela Fabiola, Puglisi Giovanni, Cavallaro Gennara, Trapani Giuseppe, Conese Massimo, Nanocomplexes for gene therapy of respiratory diseases: Targeting and overcoming the mucus barrier, Pulmonary Pharmacology & Therapeutics, 34, 2015. Crossref

  14. Beck-Broichsitter Moritz, Merkel Olivia M., Kissel Thomas, Controlled pulmonary drug and gene delivery using polymeric nano-carriers, Journal of Controlled Release, 161, 2, 2012. Crossref

  15. Zijlstra Gerrit S., Hinrichs Wouter L.J., Boer Anne H. de, Frijlink Henderik W., The role of particle engineering in relation to formulation and de-agglomeration principle in the development of a dry powder formulation for inhalation of cetrorelix, European Journal of Pharmaceutical Sciences, 23, 2, 2004. Crossref

  16. Kusmartseva O., Kattige A.S., Price R., Smith P.R., In-line assessment of pulmonary drug delivery using light obscuration, Biosensors and Bioelectronics, 20, 3, 2004. Crossref

  17. Frijlink Henderik W., de Boer Anne H., Trends in the technology-driven development of new inhalation devices, Drug Discovery Today: Technologies, 2, 1, 2005. Crossref

  18. Forbes Ben, Ehrhardt Carsten, Human respiratory epithelial cell culture for drug delivery applications, European Journal of Pharmaceutics and Biopharmaceutics, 60, 2, 2005. Crossref

  19. Beck-Broichsitter Moritz, Schmehl Thomas, Seeger Werner, Customized Vibrating-Membrane Nozzles for Enhanced Fluid Atomization, Aerosol Science and Technology, 49, 2, 2015. Crossref

  20. Gnadt Mirjam, Trammer Beatrice, Kardziev Boris, Bayliss Martin K., Edwards Chris D., Schmidt Michael, Högger Petra, Comparison of the bronchodilating effects of inhaled β2-agonists after methacholine challenge in a human lung reperfusion model, European Journal of Pharmaceutics and Biopharmaceutics, 81, 3, 2012. Crossref

  21. Hussain Alamdar, Arnold John J., Khan Mansoor A., Ahsan Fakhrul, Absorption enhancers in pulmonary protein delivery, Journal of Controlled Release, 94, 1, 2004. Crossref

  22. Melnik R.V.N., Jenkins David R., On computational control of flow in airblast atomisers for pulmonary drug delivery, International Journal of Pharmaceutics, 239, 1-2, 2002. Crossref

  23. Sebti Thami, Amighi Karim, Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation, European Journal of Pharmaceutics and Biopharmaceutics, 63, 1, 2006. Crossref

  24. Frijlink H W, De Boer A H, Dry powder inhalers for pulmonary drug delivery, Expert Opinion on Drug Delivery, 1, 1, 2004. Crossref

  25. Fasano Alessio, Pathological and Therapeutic Implications of Macromolecule Passage through the Tight Junction, in Tight Junctions, 2001. Crossref

  26. Taratula Oleh, Garbuzenko Olga B., Chen Alex M., Minko Tamara, Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA, Journal of Drug Targeting, 19, 10, 2011. Crossref

  27. Tsai Meng-Tsan, Lee I-Chi, Lee Zhung-Fu, Liu Hao-Li, Wang Chun-Chieh, Choia Yo-Chun, Chou Hsin-Yi, Lee Jiann-Der, In vivo investigation of temporal effects and drug delivery induced by transdermal microneedles with optical coherence tomography, Biomedical Optics Express, 7, 5, 2016. Crossref

  28. Vaughan Benjamin L., Grotberg James B., Splitting of a two-dimensional liquid plug at an airway bifurcation, Journal of Fluid Mechanics, 793, 2016. Crossref

  29. Beck-Broichsitter Moritz, Schmehl Thomas, Seeger Werner, Gessler Tobias, Pulmonary Drug Delivery with Nanoparticles, in Nanomedicine in Health and Disease, 2011. Crossref

  30. YAMADA Keigo, Control of Pulmonary Absorption of Drugs by Various Pharmaceutical Excipients, YAKUGAKU ZASSHI, 127, 4, 2007. Crossref

  31. Mukherjee Biswajit, Paul Paramita, Dutta Lopamudra, Chakraborty Samrat, Dhara Moumita, Mondal Laboni, Sengupta Soma, Pulmonary Administration of Biodegradable Drug Nanocarriers for More Efficacious Treatment of Fungal Infections in Lungs: Insights Based on Recent Findings, in Multifunctional Systems for Combined Delivery, Biosensing and Diagnostics, 2017. Crossref

  32. Angelo Robert, Rousseau Kathleen, Grant Marshall, Leone-Bay Andrea, Richardson Peter, Technosphere® Insulin: Defining the Role of Technosphere Particles at the Cellular Level, Journal of Diabetes Science and Technology, 3, 3, 2009. Crossref

  33. Basson E., Van Der Bijl P., Van Eyk A.D., Transvaginal Diffusion of Synthetic Peptides, European Journal of Inflammation, 5, 1, 2007. Crossref

  34. Javadzadeh Yousef, Yaqoubi Shadi, Therapeutic nanostructures for pulmonary drug delivery, in Nanostructures for Drug Delivery, 2017. Crossref

  35. ROCHE NICOLAS, HUCHON GÉRARD J., Rationale for the Choice of an Aerosol Delivery System, Journal of Aerosol Medicine, 13, 4, 2000. Crossref

  36. Bykova A. F., Ivanov I. M., Grebenyuk A. N., PROBLEMS AND PROSPECTS OF INHALATION APPLICATION OF PEPTIDE AND PROTEIN COMPOUNDS AS POTENTIAL MEDICAL RADIATION PROTECTIVE AGENTS, Medicо-Biological and Socio-Psychological Problems of Safety in Emergency Situations, 2, 2018. Crossref

  37. Taylor Glyn, Gumbleton Mark, Aerosols for Macromolecule Delivery, American Journal of Drug Delivery, 2, 3, 2004. Crossref

  38. Muradoglu M., Romanò F., Fujioka H., Grotberg J. B., Effects of surfactant on propagation and rupture of a liquid plug in a tube, Journal of Fluid Mechanics, 872, 2019. Crossref

  39. Lalan Manisha, Tandel Hemal, Lalani Rohan, Patel Vivek, Misra Ambikanandan, Inhalation Drug Therapy: Emerging Trends in Nasal and Pulmonary Drug Delivery, in Novel Drug Delivery Technologies, 2019. Crossref

  40. Daman Zahra, Gilani Kambiz, Rouholamini Najafabadi Abdolhossein, Eftekhari Hamid Reza, Barghi Mohammad Ali, Formulation of inhalable lipid-based salbutamol sulfate microparticles by spray drying technique, DARU Journal of Pharmaceutical Sciences, 22, 1, 2014. Crossref

  41. Nazar Hamde, Roldo Marta, Fatouros Dimitrios G, van der Merwe Susanna M, Tsibouklis John, Hydrogels in mucosal delivery, Therapeutic Delivery, 3, 4, 2012. Crossref

  42. Ivanov I. M., Nikiforov A. S., Yudin M. A., Chepur S. V., Proshina Yu. A., Sventitskaya A. M., Prospects for Inhalation Delivery of Medical Protectors against Radiation Damage , Biology Bulletin, 47, 12, 2020. Crossref

  43. Bohr Adam, Beck-Broichsitter Moritz, Generation of tailored aerosols for inhalative drug delivery employing recent vibrating-mesh nebulizer systems, Therapeutic Delivery, 6, 5, 2015. Crossref

  44. Morales Javier O, Peters Jay I, Williams Robert O, Surfactants: their critical role in enhancing drug delivery to the lungs, Therapeutic Delivery, 2, 5, 2011. Crossref

  45. Xu Caina, Tian Huayu, Chen Xuesi, Pulmonary Co-delivery of DOX and siRNA, in Gene Delivery, 2022. Crossref

  46. Stieger Nicole, Liebenberg Wilna, Aucamp Marique E., De Villiers Melgardt M., The Use of Dendrimers to Optimize the Physicochemical and Therapeutic Properties of Drugs, in Dendrimer‐Based Drug Delivery Systems, 2012. Crossref

  47. Thomas Biju, Pugalenthi Arun, Currently Available Inhaled Therapies in Asthma and Advances in Drug Delivery and Devices, Indian Journal of Pediatrics, 89, 4, 2022. Crossref

  48. Usmani Omar S, Inhaler Devices, in Encyclopedia of Respiratory Medicine, 2022. Crossref

  49. Fujioka Hideki, Romanò Francesco, Muradoglu Metin, Grotberg James B., Splitting of a three-dimensional liquid plug at an airway bifurcation, Physics of Fluids, 34, 8, 2022. Crossref

  50. Zhang Ji-Yuan, Liu Xiao-Xia, Lin Jia-Yi, Bao Xiao-Yan, Peng Jian-Qing, Gong Zi-Peng, Luan Xin, Chen Yi, Biomimetic engineered nanocarriers inspired by viruses for oral-drug delivery, International Journal of Pharmaceutics, 624, 2022. Crossref

Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集 価格及び購読のポリシー Begell House 連絡先 Language English 中文 Русский Português German French Spain